VERA THERAPEUTICS INC (VERA)
US92337R1014 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 160.72M | 43.50M | 79.70M | 53.70M | 3.20M | |||
| Marketable Securities | 115.03M | 71.20M | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | 100.00K | 0.00 | |||
| Other Current Assets | 11.31M | 11.00M | 2.90M | 500.00K | 300.00K | |||
| Total Current Assets | 172.02M | 125.70M | 82.50M | 54.30M | 3.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.04M | 5.20M | N/A | 0.00 | 1.40M | |||
| Investments And Advances | 11.00K | 100.00K | 900.00K | N/A | N/A | |||
| Other Non-Current Assets | 471.00K | 500.00K | 300.00K | 300.00K | 400.00K | |||
| Total Non-Current Assets | 3.52M | 5.70M | 1.20M | 300.00K | 1.80M | |||
| TOTAL ASSETS | 175.55M | 131.40M | 83.70M | 54.60M | 5.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 0.00 | 100.00K | |||
| Accrued Expenses | 11.19M | 13.60M | 5.90M | 500.00K | 400.00K | |||
| Accounts Payable | 11.12M | 12.00M | 1.40M | 900.00K | 300.00K | |||
| Other Current Liabilities | N/A | 0.00 | 400.00K | 1.00M | 200.00K | |||
| Total Current Liabilities | 22.30M | 25.60M | 7.70M | 2.40M | 1.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 49.88M | 24.80M | 4.90M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.68M | 4.10M | 1.50M | 1.90M | 800.00K | |||
| Total Non-Current Liabilities | 51.56M | 28.90M | 6.50M | 1.90M | 700.00K | |||
| TOTAL LIABILITIES | 73.86M | 54.50M | 14.20M | 4.30M | 1.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -309.10M | -213.10M | -124.10M | -91.40M | -38.00M | |||
| Additional Paid In Capital | 410.74M | 290.00M | 193.60M | 2.10M | 1.50M | |||
| Common Shares | 44.00K | 0.00 | 0.00 | 139.60M | 40.10M | |||
| Shares Outstanding | 44.45M | 27.80M | 21.30M | 20.50M | 20.50M | |||
| Tangible Book Value per Share | 2.29 | 2.77 | 3.27 | -4.36 | -1.79 | |||
| Total Shareholders' Equity | 101.69M | 76.90M | 69.60M | 50.20M | 3.50M | |||
| TOTAL LIABILITIES AND EQUITY | 175.55M | 131.40M | 83.70M | 54.60M | 5.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.49 | 0.32 | 0.07 | N/A | N/A | |||
| Current Ratio | 7.71 | 4.91 | 10.71 | 22.63 | 3.27 | |||
| Return On Assets (ROA) | -54.68% | -67.78% | -38.96% | -97.82% | -219.44% | |||
| Return On Equity (ROE) | -94.40% | -115.81% | -46.85% | -106.39% | -338.57% | |||
All data in USD